CLIA lab

CLIA 13D2274365: Affect Therapeutics Inc

Nampa, ID. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 13D2274365 belongs to Affect Therapeutics Inc in Nampa, ID.

Certificate of Waiver, effective January 3, 2025, expires January 2, 2027.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
January 3, 2025
Certificate expiration
January 2, 2027
Status in the CMS file
Active (termination code 00)
Original participation date
January 3, 2023
Facility type
Comprehensive outpatient rehab facility
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
13D2274365
Lab name
Affect Therapeutics Inc
Address
1217 E 3rd St Ste 109, Nampa, ID 83651
Phone
(845) 769-8758

Annual test volume the lab reported

Waived tests
25,000

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Nampa, ID

Related

Questions

What is the CLIA number for Affect Therapeutics Inc in Nampa?

13D2274365, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Affect Therapeutics Inc hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 13D2274365 expire?

The CMS file lists January 2, 2027 as the certificate expiration date; the certificate took effect January 3, 2025.

Try it on your own data today.

Free to start. Most teams are using it the same day.